Analysis of Tax-expressing cell lines generated from HTLV-I Tax- transgenic mice: Correlation between c-myc overexpression and neoplastic potential

Experimental Cell Research

Volumn 247, Issue 2, 1999, Pages 525-533

  Saggioro, Daniela ^a,b   D'Agostino, Donna M ^a   Chieco Bianchi, Luigi ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b Biotechnology Section of Padova   (Italy)

Author keywords

C myc; HTLV I; Tax; Transformation

Indexed keywords

MYC PROTEIN; TAX PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; HUMAN T CELL LEUKEMIA VIRUS 1; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALIA; HTLV; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; MUS MUSCULUS;

EID: 0033558807     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1998.4381     Document Type: Article

References (42)

1. Poiesz B. J., Ruscetti F. W., Gazdar A. F., Bunn P. A., Minna J. D., Gallo R. C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl. Acad. Sci. USA. 77:1980;7415-7419.
2. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., De The G. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet. 2:1985;407-410.
3. Rabson A. B., Graves B. J. Synthesis and processing of viral RNA. Retroviruses. 1997;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 205-262.
4. Fujisawa J., Seiki M., Kiyokawa T., Yoshida M. Functional activation of the long terminal repeat of human T-cell leukemia virus type I by trans-acting factor. Proc. Natl. Acad. Sci. USA. 82:1985;2277-2281.
5. Yoshida M. Multiple targets of HTLV-I for dysregulation of host cells. Semin. Virol. 7:1996;349-360.
6. Perini G., Wagner S., Green M. R. Recognition of bZIP proteins by human T-cell leukaemia virus transactivator Tax. Nature. 376:1995;602-605.
7. Baranger A. M., Palmer R. C., Hamm M. K., Giebler H. A., Brauweiler A., Nyborg J. K., Schepartz A. Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax. Nature. 376:1995;606-608.
8. Giebler H. A., Loring J. E., Van Orden K., Colgin M. A., Garrus J. E., Escudero K. W., Brauweiler A., Nyborg J. K. Anchoring of CREB binding protein to the human T-cell leukemia virus type I promoter: a molecular mechanism of tax transactivation. Mol. Cell. Biol. 17:1997;5156-5164.
9. Zhao L.-J., Giam C.-Z. Interaction of the human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator Tax with cellular factors that bind specifically to the 21-base-pair repeats in the HTLV-I enhancer. Proc. Natl. Acad. Sci. USA. 88:1991;11445-11449.
10. Suzuki T., Fujisawa J., Toita M., Yoshida M. The transactivator Tax of human T-cell leukemia virus type 1 (HTLV-1) interacts with cAMP responsive element (CRE) binding and CRE modulator proteins that bind to the 21-base-pair enhancer of HTLV-I. Proc. Natl. Acad. Sci. USA. 90:1993;610-614.
11. srf. Genes Dev. 6:1992;2066-2076.
12. Suzuki T., Hirai H., Fujisawa J., Fujita T., Yoshida M. A trans-activator Tax of human T-cell leukemia virus type I binds to NF-kB p50 and serum responsive factor (SRF) and associates with enhancer DNAs of the NF-kB site and CArG box. Oncogene. 8:1993;2391-2397.
13. Lanoix J., Lacoste J., Pepin N., Rice N. R., Hiscott J. Overproduction of NFKB2 (lyt-10trans. Oncogene. 9:1994;841-852.
14. Grassmann R., Berchtold S., Radant I., Alt M., Fleckenstein B., Sodroski J. G., Haseltine W. A., Ramstedt U. Role of human T-cell leukemia virus type I X-region proteins in immortalization of primary human lymphocytes in culture. J. Virol. 66:1992;4570-4575.
15. Tanaka A., Takahashi C., Yamaoka S., Nosaka T., Maki M., Hatanaka M. Oncogenic transformation by thetaxin vitro. Proc. Nat. Acad. Sci. USA. 87:1990;1071-1075.
16. Pozzati R., Vogel J., Jay G. The human T-lymphotropic virus type Itax. Mol. Cell. Biol. 10:1990;413-417.
17. Saggioro D., Majone F., Forino M., Turchetto L., Leszl A., Chieco-Bianchi L. Tax protein of human T-lymphotropic virus type I triggers DNA damage. Leukemia Lymphoma. 12:1994;281-286.
18. Nerenberg M., Hinrichs S. H., Reynolds R. K., Khoury G., Jay G. Thetat. Science. 237:1987;1324-1329.
19. Hinrichs S. H., Nerenberg M., Reynolds R. K., Khoury G., Jay G. A transgenic mouse model for human neurofibromatosis. Science. 237:1987;1340-1343.
20. Grossman W. S., Kimata J. T., Wong F.-H., Zutter M., Ley T. J., Ratner L. Development of leukemia in mice transgenic for thetax. Proc. Nat. Acad. Sci. USA. 92:1995;1057-1061.
21. Green J. E., Hinrichs S. H., Vogel J., Jay G. Exocrinopathy resembling Sjogren's syndrome in HTLV-I tax transgenic mice. Nature. 34:1989;72-74.
22. Iwakura Y., Tosu M., Yoshida E., Takiguchi M., Sato K., Kitajiama I., Nishioka K., Yamamoto K., Takeda T., Hatanaka M., Yamamoto H., Sekiguchi T. Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science. 253:1991;1026-1028.
23. Saggioro D., Rosato A., Esposito G., Rosenberg M. P., Harrison J., Felber B. K., Pavlakis G. N., Chieco-Bianchi L. Inflammatory polyarthropathy and bone remodelling in HTLV-I tax-transgenic mice. J. AIDS Hum. Retrovirol. 14:1997;272-280.
24. Ruddle N. H., Li C.-B., Horne W. C., Santiago P., Troiano P., Jay G., Horowitz M., Baron R. Mice transgenic for HTLV-I LTR-tax. Virology. 197:1993;196-204.
25. Ozden S., Coscoy L., Gonzalez-Dunia D. Transgenic models: An overview. J. AIDS Hum. Retrovirol. 13:1996;54s-161s.
26. Calabro' M. L., Luparello M., Grottola A., Del Mistro A., Fiore J. R., Angarano G., Chieco-Bianchi L. Detection of human T lymphotropic virus type II/b in human immunodeficiency virus type 1-coinfected persons in southeastern Italy. J. Infect. Dis. 168:1993;1273-1277.
27. Yang J.-Q., Bauer S. R., Mushinski J. F., Marcu K. B. Chromosome translocations clustered 5' of the murine c-myc gene qualitatively affected promoter usage: Implications for the site of normal c-myc regulation. EMBO J. 4:1985;1441-1447.
28. Curran T., Peters G., Van Beveren C., Teich N. M., Verma I. M. FBJ murine osteosarcoma virus: Identification and molecular cloning of biologically active proviral DNA. J. Virol. 44:1982;674-682.
29. D'Andrea E., Tessarollo L., Menin C., Chieco-Bianchi L. Tumors induced by Moloney murine sarcoma virus are clonal in rats, not clonal in mice. J. Cancer Res. Clin. Oncol. 118:1992;141-146.
30. Sodroski J. G., Rosen C. A., Haseltine W. A. trans. Science. 225:1984;381-385.
31. Graham F. J., Van der Eb A. J. A new technique for the assay of infectivity of human adenovirus. Virology. 5:1973;456-460.
32. Saggioro D., Forino M., Penzo A., Pesce M., Oliviero S., Chieco-Bianchi L. Tax-induced HTLV-I LTR transcriptional activation is modulated by phosphorylation. Biochem. Biophys. Res. Commun. 205:1994;666-673.
33. Hanly S. M., Rimsky L. T., Malim M. H., Kim J. H., Hauber J., Dodon M. D., Le S.-Y., Maizel J. V., Cullen B. R., Greene W. C. Comparative analysis of the HTLV-I Rex and HIV-1 Revtrans. Gene Dev. 3:1989;1534-1544.
34. Chlichlia K., Moldenhauer G., Daniel P. T., Busslinger M., Gazzolo L., Schirrmacher V., Khazaie K. Immediate effects of reversible HTLV-Itax. Oncogene. 10:1995;269-277.
35. Inoue H., Yamaoka S., Imamura M., Hatanaka M. Suppression of the transformed phenotype in hybrids of human T-cell leukemia virus type I tax-transformed rat fibroblasts and normal human fibroblasts. Exp. Cell Res. 215:1994;68-74.
36. Duyao M. P., Kessler D. J., Spicer D. B., Bartholomew C., Cleveland J. L., Siekevitz M., Sonenshein G. E. Transactivation of thec-myctax. J. Biol. Chem. 267:1992;16288-16291.
37. Benvenisty N., Ornitz D. M., Bennett G. L., Sahagan B. G., Kuo A., Cardiff R. D., Leder P. Brain tumors and lymphomas in transgenic mice that carry HTLV-I LTR/c-myctax. Oncogene. 7:1992;2399-2405.
38. Terradillos O., Billet O., Renard C.-A., Levy R., Molina T., Briand P., Buendia M. A. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene. 14:1997;395-404.
39. Williams J. S., Andrisani O. M. The hepatitis B virus protein targets the basic region-leucine zipper domain of CREB. Proc. Natl. Acad. Sci. USA. 92:1995;3819-3823.
40. Koizumi T., Nakao Y., Kawanishi M., Maeda S., Sugiyama T., Fujita T. Suppression of c-myc RNA expression by steroid hormones in HTLV-I-infected T-cell line, KH-2. Int. J. Cancer. 44:1989;701-706.
41. Fujita M., Shiku H. A human T lymphotropic virus type I (HTLV-I) long terminal repeat-directed antisense c-myc construct with an Epstein-Barr virus replicon vector inhibits cell growth in a HTLV-I-transformed human T cell line. FEBS Lett. 322:1993;15-20.
42. Miyazaki T., Liu Z.-J., Taniguchi T. Selective cooperation of HTLV-I-encoded p40tax-1 with cellular oncoproteins in the induction of hematopoietic cell proliferation. Oncogene. 12:1996;2403-2408.